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Recent studies have revealed pleiotropic anticancer and antiproliferative capabilities of Dioscorea nipponica Makino whereas the
eﬀect ofthis planton metastasisofcancer cells has notbeen clearly clariﬁed.In the present study, we extracted Dioscorea nipponica
Makino with methanol (DNE1), chloroform (DNE2), ethyl acetate (DNE3), n-butanol (DNE4), and water (DNE5). We ﬁrst
demonstrate that DNE3 was found to be eﬀective in reducing the lung metastases formation by about 99.5% as compared to
vehicle-treated control animals. When a nontoxic concentration of the extract was treated directly to highly metastatic murin
melanomacells(B16F10)andhumanmelanomacells(A2058)invitro, itexerted adose-dependent inhibitoryeﬀectontheinvasion
(P<. 001), motility (P<. 001), secretion of MMPs (P<. 001), and u-PA (P<. 001) of both cell lines. To investigate the possible
mechanisms involved in these events, we performed western blot analysis to ﬁnd that DNE inhibited phosphorylation of Akt.
A treatment with DNE3 to B16F10 cells also inhibited the activation of NF-κB and increased the expression of IkappaB. Taken
together, these ﬁndings suggested that DNE3 could reduce the metastasis of melanoma cells, thereby constituting an adjuvant
treatment for metastasis control.
1.Introduction
Epidemiological studies have shown that a diet rich in
vegetables and fruits might protect against cancer by mech-
anisms that have not been well deﬁned yet. In recent
years, naturally occurring plant products have been getting
increasedattentionfortheinterventionofmalignantinvasive
progression in the late stage of neoplastic diseases [1, 2].
On the basis of this idea, certain foods, including many
vegetables, fruits, and grains, as well as phytochemicals of
diversiﬁed pharmacological eﬃcacies have been shown to
oﬀer a signiﬁcant protection against various cancers [3–5].
Furthermore, there is an increase focus on providing sci-
entiﬁc basis to use these agents in the prevention strategy
for people with a high risk for cancers. Dioscorea nipponica
Makino has long been used as a folk medicine for bronchitis,
asthma, and rheumatoid arthritis. These compounds were
eﬀective for preventing both the body and adipose tissue
weight gains in rodents induced by a high-fat diet [6].
However, limited studies are available concerning the eﬀect
of Dioscorea nipponica Makino in anticancer.
Invasion and metastasis of solid tumor involves multiple
processes and various cytophysiological changes, including
changed adhesion capability between cells and extracellular2 Evidence-Based Complementary and Alternative Medicine
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Figure 1 :T h ec h e m i c a lp r o ﬁ l eo fDioscorea nipponica extract was analyzed by HPLC-mass spectrometry. (a) Procedure for fractionation of
the extracts from Dioscorea nipponica. (b) B16F10 cells were treated with these fractions by Transwell invasion assay. (c) Chromatographic
patterns from HPLCanalysisof DNE3 extracts showed peaks corresponding to the retention times (minutes). Absorbance was monitored at
254nm. (d) The main product peak (P1) with a retention time of 16.644 minutes was then subjected to mass spectrometer.
matrix (ECM) and damaged intercellular interaction [7].
Degradation of ECM by cancer cells via protease, such as
metalloproteinases (MMPs), serine proteinases, plasmino-
genactivator(PA),andcathepsins,mayleadtotheseparation
of intercellular matrix to promote the motility of cancer cells
and eventually lead to invasion and metastasis. Among these
peoteinase, MMP-2 and MMP-9 are type IV collagenases
that degrade basement membrane collagen [8]. These two
MMPs are expressed in many diﬀerent types of cancer cells;
however, they are predominately produced in stromal cells
located adjacent to the tumors [9]. In human malignancies,
increased MMP-2 and MMP-9 activity and expressionEvidence-Based Complementary and Alternative Medicine 3
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Figure 2: Suppression of lung metastasis of melanoma cells by DNE3. Melanoma cells were injected into the tail veins of 6-week-old male
C57BL/6 mice. After injection of melanoma cells, DNE3 (0.1g/kg/day and 0.2g/kg/day) and vehicle (saline) alone were administered oral
gavage for21 days. Mice were sacriﬁced and then analyzed for representative photographs of lungs (a), the weight of lung (b), the number of
lung metastasis (c), and the body weight of mice (d). Results were statistically evaluated by using one-way ANOVA with post-hock Dunnett’s
test (
∗∗∗P <. 001).
correlate with reduced survival and poor disease prognosis
[10–13].
However, these studies on functions of Dioscorea nip-
ponica Makino have been mainly focused on the eﬀects of
antiallergic property or antiobesity whereas the eﬀect of this
plant on migration and invasion of tumor cells has not been
clearly clariﬁed. The purpose of the present study was to
characterize the eﬀects of Dioscorea nipponica Makino on
tumor cell metastasis in vivo, and cell invasion, migration,
motility, adhesion, and proteinase expression in vitro.
2.Methods
2.1. Chemicals. Dioscorea nipponica Makino was obtained
from a plantation of the Green Health Biotechnology
Corporation (Yunlin, Taiwan) and identiﬁed by Profes-
sor Yih-Shou Hsieh, Chung Shan Medical University.
3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bro-
mide (MTT) and Dulbecco’s modiﬁed Eagle medium
(DMEM)wereobtainedfromSigmaChemicalCo.(St.Louis,
MO, USA)and Matrigel was purchased from BD Biosciences
(Bedford, MA, USA). Rabbit polyclonal antibodies against
c-Jun and c-Fos were purchased from Biosource (Camar-
illo, CA, USA) and a rabbit polyclonal antibody against
tissue inhibitor of matrix metalloproteinase-2 (TIMP-2)
was purchased from Serotec (Oxford, UK). Monoclonal
antibodies against nuclear factor-κB( N F - κB) and C23 and
rabbit polyclonal antibodies against Extracellular signal-
regulated kinase 1/2 (ERK1/2), p38, and Akt, the total and
phosphorylated protein, were purchased from Santa Cruz4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Histopathology of lung of metastatic tumor bearing animals (×100). Lungs of the metastasis-induced animals were ﬁxed in
neutral buﬀered formalin and stained with hematoxyline and eosine. (a) Control (melanoma + saline), (b) normal lung (wild type, WT),
(c) melanoma + 0.1g/kg/day DNE3, and (d) melanoma + 0.2g/kg/day DNE3. Arrows showed areas of metastatic nodules (tumor).
Biotechnology Inc. (Santa Cruz, CA, USA). A monoclonal
antibody against plasminogen activator inhibitor (PAI) was
obtained from American Diagnostics Inc. (Greenwich, CT,
USA). ECL Plus detection kit was obtained from Amersham
Life Sciences, Inc. (Piscataway, NJ). Lightshift kit was
purchased from Pierce (Rockford, IL, USA).
2.2. Preparation of Dioscorea nipponica Makino Extracts. Air-
dried Dioscorea nipponica Makino (50g) was extracted 3
times with boiling water (500mL) for 30 minutes, and
the ﬁltrate was partitioned with chloroform (DNE2), ethyl
acetate (DNE3), and n-butanol (DNE4), and the residue was
extracted with methanol (DNE1). Afterwards, solvent was
removed by a vacuum rotary evaporator and these fractions
were lyophilized and stored at −20◦C . Furthermore, the
chemicalproﬁleofethylacetatesolublefraction wasanalyzed
by using high-pressure liquid chromatograms- (HPLC-)-
mass spectrometer. Brieﬂy, DNE3 was analyzed by HPLC-
mass spectrometer using a HPLC (Hitachi L-6200 with an
L-4500 Diode Array detector) with a PE Sciex Qstar Pulsar
ESI-TOF mass spectrometer. Samples (10μl) were injected
into a Merck LiChrospher 100 RP-18 column (4 × 250mm).
The column was equilibrated in 0.05% acetic acid/water
(solution A), and elution of the components was performed
by increasing the concentration of acetonitrile (solution B)
from 0% to 60% in 30 minutes at a ﬂow rate of 1mL/min.
The main product peak with a retention time of 16.644
minutes was then subjected to electrospray ionisation mass
spectra using multiply-charged ion proﬁle based on the
m o d i ﬁ e dm e t h o do fW o n ge ta l .[ 14].
2.3. Cell Culture. Cell lines including A2058 from human
melanoma, B16F10 from a mouse melanoma, and HS68
from a human foreskin ﬁbroblast cells were obtained from
American Type Culture Collection (Rockville, MD, USA)
and cultured in DMEM (for A2058 and B16F10) or RPMI
(for HS68).
2.4. Measurement of Lung Metastasis in B16F10-Bearing
Mice. C57BL/6 male mice of 5-week-old (National Taiwan
University Animal Center, Taiwan) were housed with a
regular 12-hour light/12-hour dark cycle and ad libitumEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: The eﬀects ofDNE3 on cell viability, migration,motility, invasion,andadhesion ofmelanomacells. (a)B16F10and(b) HS68cells
were treated with DNE3 for24hours by MTT assay.(c) B16F10cells were subjected to analyze forcell migrationby wound healingassay.(d)
Determined migration ability of B16F10 was subsequently quantiﬁed with that of control being 100% (without DNE3 for 48h). Cells were
treated withDNE3 for24 hours and thensubjected to analyzefor (eand f) motility, invasion,and (g) adhesionasdescribed in Materialsand
Methods. Results were statistically evaluated by using one-way ANOVA with post hoc Dunnett’s test (
∗∗∗P <. 001). Results from 3 repeated
and separated experiments were similar.
access to standard rodent chow diet(Laboratory RodentDiet
5001,LabDiet,St.Louis,MO).Cells(2×105 cells)suspended
in 0.1mL of PBS were injected into the tail vain of C57BL/6
mice. On the following day (Day 1), mice were randomly
divided into three groups (n = 8 for each group) to be
fed by oral gavage with saline (control) or DNE3 (0.1g/kg
and 0.2g/kg of body weight, daily). Five untreated mice
were used as wild type control. After 21 days, animals were
euthanized with CO2. The lungs were isolated and weighed,
and metastatic nodules on the surface of lungs were counted
under a microscopy. Lungs were ﬁxed in neutral buﬀered
5% formalin, and sections were taken and stained with
hematoxyline and eosine for morphological studies [15].
2.5. Determination of Cell Viability (MTT Assay). Cells were
treated with DNE3 (0, 25, 50, 75, and 100μg/mL) for 24
hours. After treatment, cells were incubated with 0.5mg/mL
MTT in culture medium for an additional 4h, and the blue
formazan crystals of viable cells were dissolved by lysis buﬀer
(isopropyl alcohol containing 10% Triton X-100 and 0.1N
HCl) and measured spectrophotometrically at 570nm [4].
2.6. Transwell Cell Invasion and Motility Assays. After a pre-
treatment with DNE3 for 24 hours, cells were harvested and
seeded to BD Falcon cell culture inserts (BD Biosciences,
Bedford, MA, USA) at 5 × 104 cells/well in serum-free
medium and then incubated for another 12h at 37◦C. For
invasion assay, 100μl Matrigel (1mg/1mL) was applied to
themembrane ﬁlters with a pore size of8μma n dth ebott om
chamber contained standard medium. Filters were then air-
dried for 5h in a laminar ﬂow hood. The invaded cells were
ﬁxed with methanol and stained with Giemsa. Cell numbers
were counted under a light microscope. The motility assay
was carried out as described in the invasion assay with no
coating of Matrigel [16].
2.7. Wound Healing Migration Assay. Wounds were intro-
duced to the conﬂuent monolayer of cells with a yellow
plastic pipette tip to create a cleared line. The medium was
removed and replaced with DMEM containing 1% FBS, and
thenDNE3was added. The cells were incubated at 37◦C,and
cell movement into the wound area was photographedat 0h,
24 hours and 48 hours using a microscope.
2.8. Cell-Matrix Adhesion Assay. After a 24-hour treatment
with DNE3, cells were plated on 24-well dishes coated
with 150μl type I collagen (10μg/mL) and cultured for 30
minutes.NonadherentcellswereremovedbyPBSwashesand
adherent cells were ﬁxed in ethanol. After staining with 0.1%
crystal violet, ﬁxed cells were lysed in 0.2% Triton X-100 and
the absorbance was measured at 550nm [17].
2.9. Determination of MMP-2, -9, and u-PA. In gelatin
zymography, collected media were prepared with sodium
dodecyl sulphate (SDS) sample buﬀer without boiling or
reduction and subjected to 0.1% gelatin-8% SDS polyacry-
lamide gel electrophoresis (SDS-PAGE) to determine the
MMPs. After electrophoresis, gels were washed with 2.5%
Triton X-100 and then incubated in reaction buﬀer (40mM
Tris-HCl, pH 8.0, 10 mM CaCl2, 0.01% NaN3)f o r1 6ha t
37◦C. Then gel was stained with Coomassie brilliant blue
R-250 [17].Evidence-Based Complementary and Alternative Medicine 7
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Figure 5: Eﬀects of DNE3 on the protein levels of proteases and their endogenous inhibitors. Cells were treated with DNE3 for 24 hours
and then condition media were subjected to gelatin zymography and casein zymography to analyze the activities of MMP-2 (a) and u-PA
(b), respectively. Cell lysate were subjected to Western blot to analyzethe expression of MMP-2 (c) and TIMP-2 (d). Results were statistically
evaluated by using one-way ANOVA with post hoc Dunnett’s test (
∗P <. 05;
∗∗∗P <. 001).
Visualization of u-PA activity was performed by casein
zymography as previously described [17]. Brieﬂy, 2% w/v
casein and 20μg/mL plasminogen were added to 8% SDS-
PAGE gel, and then performed as described in the gelatin
zymography.
2.10. Activating Protein-1 (AP-1) and NF-κB Binding Assay.
Binding of AP-1 and NF-κB in nuclear extracts was assessed
by electrophoretic mobility shift assay (EMSA) with biotin-
labeled double-stranded AP-1 or NF-κB oligonucleotides,
and EMSA was carried out by using the Lightshift kit.
Brieﬂy, binding reactions containing 10μgo fn u c l e a r
protein, 10mM Tris, 50mM KCl, 1mM DTT, 5mM MgCl2,
2μg poly (dI·dC), and 2pmolof oligonucleotideprobewere
incubated for 20 minutes. Speciﬁc binding was conﬁrmed
by using a 200-fold excess of unlabeled probe as speciﬁc
competitor. Protein-DNA complexes were separated by8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Inhibitory eﬀect of DEN3 on the phosphorylation of Akt. B16F10 cells were cultured in various concentrations of DNE3 for
24 hours, and then cell lysates were subjected to SDS-PAGE followed by Western blotting with anti-PI3K (a), anti-phospho-Akt (b), anti-
phospho-p38 (c), and anti-phospho-ERK1/2 (d) antibodies. Signals of proteins were visualized with an ECL detection system. Determined
activities of these proteins were subsequently quantiﬁed by densitometric analysis with that of control being 100% (deﬁned as 1.0) as shown
just below the gel data. Results were statistically evaluated by using one-way ANOVA with post hoc Dunnett’s test (
∗∗∗P <. 001).Evidence-Based Complementary and Alternative Medicine 9
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Figure7:EﬀectsofDNE3ontheactivationofNF-κB,c-Jun,andc-Fos.CellsweretreatedwithDNE3 andthennuclearextracts wereanalysed
for DNA binding activity of NF-κB (a) and AP-1 (b) using biotin labeled NF-κB and AP-1 speciﬁc oligonucleotide in EMSA. The last lane
represented nuclearextracts incubated withunlabeled oligonucleotide(comp)toconﬁrmthespeciﬁcityofbinding.Nuclearandcytoplasmic
extracts were subjected to SDS-PAGE followed by western blotting with anti-NF-κB, c-Fos, c-Jun, or C23 antibodies (c) and anti-IkBα or
β-actin antibodies, respectively. Signalsofproteins were visualizedwithan ECL detection system.The experiments were repeated three times
with similarresults.
using a 6% nondenaturing acrylamide gel electrophoresis
and then transferred to positively charged nylon membranes
and crosslinked in a Stratagene crosslinker. Gel shifts
were visualized with a streptavidin-horseradish peroxidase
followed by chemiluminescent detection [18].
2.11. Western Blot Analysis. Samples were separated in a
10%polyacrylamide geland transferred ontoa nitrocellulose
membrane as previously described [17]. The blot was
subsequentlyoperated with standard procedures and probed
with each speciﬁc antibody at 4◦C overnight. The protein
expression wasdetectedby chemiluminescenceusing anECL
Plus detection kit and relative photographic density was
quantitated by scanning the photographic negatives on a gel
documentation and analysis system.
2.12. Statistical Analysis. Statistical signiﬁcances were ana-
lyzed by one-way analysis of variance (ANOVA) with post-
hockDunnett’stest.P-value ≤ .05wasconsideredstatistically
s i g n i ﬁ c a n t( S i g m a - S t a t2 . 0 ,J a n d e lS c i e n t i ﬁ c ,S a nR a f a e l ,C A ,
USA).
3.Results
3.1. Eﬀects of DNE on the Invasion of Human Melanoma Cells.
To evaluate the bioactive compound of Dioscorea nipponica
Makino, we successively extracted the Dioscorea nippon-
ica with methanol (DNE1), chloroform (DNE2), ethyl
acetate (DNE3), n-butanol (DNE4), and water (DNE5)
(Figure 1(a)). B16F10 cells were treated with diﬀerent
Dioscorea nipponica extracts, and a decrease of invasion was
detected by Transwell invasion assay. Among these extracts,
DNE3 was the most eﬀective Dioscorea nipponica ingredient
that reduces invasion activity in our assay (Figure 1(b)).
Chromatographic patterns from HPLC analysis of DNE3
extracts showed peaks corresponding to the retention times.
Absorbance was monitored at 254nm (Figure 1(c)). The
main product peak (P1) with a retention time of 16.644
minutes as shown in Figure 1(c) was then subjected to
electrospray ionisation mass spectra using multiply-charged
ion proﬁle (Figure 1(d)).
3.2. Inhibition of the Lung Colonization of B16F10 Melanoma
by the Treatment of DNE3. Recent studies have shown that10 Evidence-Based Complementary and Alternative Medicine
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Figure 8: The eﬀects of DNE3 on cell motility, invasion, and the activity of MMPs and uPA of A2058 human melanoma cells. Cells were
treated with DNE3 for 24 hours and then subjected to analyze for motility ((a) and (c)) and invasion ((b) and (d)). Condition media were
subjected to gelatin zymography and casein zymography to analyze the activities of MMPs (e) and u-PA (f), respectively. Data represented
the mean±SD of at least 3 independent experiments. Results were statisticallyevaluated by using one-wayANOVA with post hoc Dunnett’s
test (
∗P <. 05;
∗∗P <. 01;
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B16F10 cells mainly form lung tumors. C57BL/6 mice were
injected via the tail vein with B16F10 melanoma cells, and
administration of the ethyl acetate extracts of DEN3 reduced
pulmonary metastasis formation of B16F10 cells. Within 21
days of injection, the control mice were visibly riddled with
metastatic tumor nodules compared with the lungs of DNE3
treated mice (Figure 2(a)). Mean lung weights for animals
receiving 0.1g/kg/day DNE3 (0.1964 ± 0.0594g; P<. 001)
and 0.2g/kg/day DNE3 (0.1240 ± 0.0125g; P<. 001) were
signiﬁcantlylowerthanthosefromcontrolanimals (0.4570±
0.1488g; Figure 2(b)). Vehicle-treated control animals had
massive growth of tumor and was given an arbitrary-
maximum countable number about 275 ± 45.3. It was
reduced to 14 ± 5.4( 0 . 1g / k g / d a y ;P<. 001) and 1.2 ± 1.7
(0.2g/kg/day; P<. 001) countable colonies by DNE3
treatment (Figure 2(c)). The average body weight of DNE3
treated mice was higher than control group (Figure 2(d)).
Histopathologyof the lung also showed marked reduction in
tumormassinthelungsofDNE3-treatedanimals(Figure 3).
3.3. Eﬀect of DNE3 on Cell Viability. Results of MTT assay
showed that DNE3 has no cytotoxicity on B16F10 cells
(Figure 4(a)). Results from same procedures performed on
normal human foreskin ﬁbroblast cell lines, HS68, revealed
that this compound did not have any signiﬁcant cytotoxicity
on these cells (Figure 4(b)).
3.4. Eﬀects of DNE3 on the Invasion, Motility, Migration, and
Adhesion. Incubation of B16F10 with 1% FBS produced a
marked cell migration in the wound area 24 hours and
48 hours after wounding whereas wounds treated with
DNE3 showed signiﬁcant delays in wound healing under the
same conditions (Figures 4(c) and 4(d)). To screen for the
preventive eﬀectors against cancer metastasis, the inhibitory
eﬀect of DNE3 on invasion and motility of B16F10 cells
was examined with Transwell. The result showed that DNE3
signiﬁcantly reduced the motility and invasion of B16F10
cellsin a concentration-dependentmanner (Figures 4(e)and
4(f)).
Cancer cells, invading the host tissue, break from their
cell-cell contacts and make new contact with the ECM.
Therefore, DNE3 was tested to determine their eﬀects on
the cell-matrix adhesion. The results showed that DNE3
signiﬁcantly reduced the cell-matrix interactions of B16F10
cells (Figure 4(g)).
3.5. Eﬀects of DNE3 on the Activities of MMP-2, u-PA,
and TIMP-2. Via gelatin and casein zymography assays,
respectively, it has been shown that DNE3 signiﬁcantly
reduced MMP-2 (Figure 5(a))a n du - P A( Figure 5(b))a c t i v -
ity in dose-dependent manner. The immunoblotting showed
that MMP-2 protein level was gradually decreased along
with the concentration of DNE3 (Figure 5(c)). Physiological
activity of MMP-2 is greatly related to that of their speciﬁc
endogenous inhibitors, TIMP-2, therefore western blotting
was employed to see the eﬀect of DNE3 on TIMP-2
expression, and results showed that TIMP-2 protein levels
were signiﬁcantly increased along with the concentration of
DNE3 in B16F10 (Figure 5(d)).
3.6. The Inhibition of Akt Phosphorylation by DNE3. The
immunoblotting showed that PI3K protein level was grad-
ually decreased along with the concentration of DNE3
(Figure 6(a)). DNE3 signiﬁcantly inhibited the activation of
Akt as evidenced by a decrease in the levels of phospho-Akt
proteins in a dose-dependent manner (Figure 6(b))w h e r e a s
it has no signiﬁcant eﬀect on p38 and ERK1/2 activity
(Figures 6(c) and 6(d)).
3.7. Eﬀects of DNE3 on the Activation of NF-κB, c-Jun, and c-
Fos. To examine the eﬀect of DNE3 on the activation of NF-
κB and AP-1, B16F10 cells were treated with DNE3 for 24
hours. Nuclear extract was analyzed by EMSA for AP-1 and
NF-κB DNA binding activity, and results showed that DNA
binding activity of NF-κB( Figure 7(a))w a ss i g n i ﬁ c a n t l y
inhibited by a treatment with 100μg/mL DNE3 whereas the
AP-1 activity was unchanged (Figure 7(b)). Subsequently,
western blot was performed to further conﬁrm these results,
anditwasfoundthatapretreatment ofDNE3suppressedthe
nuclear levels of NF-κB while it has no signiﬁcant eﬀect on
the c-Jun and c-Fos expression, with C23 being the internal
control (Figure 7(c)). The activity of NF-κB is related to
that oftheir endogenousinhibitors, IkappaB (IκB), therefore
Western blotting was employed to see the eﬀect of DNE3 on
IκB expression, and results showed that IκBp r o t e i nl e v e l s
were signiﬁcantly increased along with the concentration of
DNE3 (Figure 7(d)).
3.8. DNE3 Inhibit Invasion and MMP-2 and u-PA Secretion
in Human Melanoma Cell Lines. Similar experiments were
performed, using human melanoma cells, A2058, in order to
determine if the anti-invasive activity of DNE3 can generally
be applicable to other types of melanoma cells. DNE3
inhibited the motility (Figures 8(a) and 8(c))a n di n v a s i o n
(Figures 8(b)and 8(d)) ofA2058cell lines, and DNE3clearly
inhibited the secretion of MMP-2, MMP-9 (Figure 8(e)),
and u-PA (Figure 8(f)), thus indicating that DNE3 might
have anti-invasive properties against a broad spectrum of
melanoma cells.
4.Discussionand Conclusions
Chemopreventive properties have long been attributed to
phenolic compounds present in the human diet and are
the use of agents to delay, inhibit, or reverse tumorigenesis.
These natural substances are of interest as they are potential
sources of anticancer compounds with minimal debilitating
toxicity and side eﬀects [19–21]. In the present study,
we demonstrated that Dioscorea nipponica are eﬀective in
various aspects of tumor formation in the B16F10 mouse
melanoma model in vitro. This model was chosen on the
basis of aggressive behavior and high metastatic potential
of this cell line. One day after the intravenous injection of
tumor cells, mice were treated with daily oral administration12 Evidence-Based Complementary and Alternative Medicine
of the DNE3 and resulted in a signiﬁcant, dose-dependent
delay in lung colonization.
The metastatic process comprises a series of complicated
events that can be subdivided into a number of steps involv-
ing cell motility, cell invasion, surface adhesion properties,
and degradationofECM.Thus, inthe presentstudy, we tried
to investigate the antimetastatic activity of DNE3 associated
with tumor thrombosis by tumor cell invasion, migration,
adhesion, and proteinase expression.
Adhesive interaction of tumor cells to ECM and its inva-
sive action into ECM are known to be fundamental events
in tumor metastatic process [22]. Here, DNE3 inhibited the
adhesion of B16-F10 cells to type I collagen, one of the ECM
components, as well as eﬀectively suppressed the invasion of
B16-F10 cells in a concentration-dependent manner.
The secretion of extracellular proteases plays an impor-
tant role in cancer cell invasion and metastasis [23]. Of
these proteases, MMPs, a family of zinc-dependent ECM-
degrading enzymes, are involved in invasion, migration,
and angiogenesis in tumor cells. There have been reports
suggesting that the expression of MMP-2 and MMP-9
correlates with the progression of various types of tumors
[24] .I na d d i t i o nt oM M P s ,t h es e r i n ep r o t e a s eu - P A
converts inactive plasminogen into plasmin and therefore
plays a key role to initiate a cascade of proteolytic steps
accumulating in the degradation of the extracellular matrix.
u-PA is found in cellular structures at the leading edge of
migrating cells that are involved in cell adhesion, migration,
invasion, and metastatsis [25]. MMP-2 is a proteolytic
enzyme capable of degrading the structural support network
for normal and malignant cells, and their expression and
activity against matrix macromolecules have been shown
to overbalance their endogenous inhibitors. TIMP-2 has
been shown to suppress tumor growth and metastatic
p o t e n t i a li nc e l la n da n i m a lm o d e ls y s t e m s[ 26]. The
data presented here demonstrated that DNE3 inhibits the
invasionofmelanomacancercellsandthisinhibitoryactivity
appeared to be dependent on the decreased expression of
MMP-2, MMP-9, and u-PA, while that of TIMP-2 was
enhanced.
The role of PI3K-Akt and MAPKs pathways in the
regulation of u-PA or MMPs expressions in carcinoma
cells has been well studied [23]. It has been shown that
an inhibition of p-Akt may lead to a reduction in the
expression of MMP-2 or u-PA as well as in the invasion
of tumor cells. As shown in Figure 6, DNE3 could reduse
the phosphorylation of Akt in B16-F10 cells. To make a
linkage between p-Akt and protease expressions, the eﬀects
of DNE3 on several transcription factors were examined. It
is well known that the activation of AP-1 and NF-κBa n d
thedownstream ofthe PI3K-Aktpathwayare associated with
inﬂammation, cell invasion, migration, and angiogenesis
[27], and that suppression of any of these transcription
factors is potentially an eﬀective means to block tumor
invasion or metastasis, as well as blocking the factors that
bind to these regulatory elements, and therefore represents
an appropriate approach to inhibit the synthesis of MMPs or
u-PA. In our studies, DNE3 was found to eﬀectively suppress
the DNA binding activity and the expression of NF-κBw h i l e
the protein level of IκB, the endogenous inhibitor of NF-
κB, was gradually increased along with the concentration of
DNE3.
The major drawbacks of many eﬀective cancer chemo-
therapeutic agents are systemic toxicity and drug resistance.
Inthisregard,dietarysupplementaswellasphytotherapeutic
agents with high anticancer activity and less toxicity to
normal tissues has been suggested as possible candidates
for their capability to improve the eﬃcacy of anticancer
drugs [28, 29]. In the present study, HS68, human foreskin
ﬁbroblast cells, was used to demonstrate that DNE3 exerted
no cytotoxicity on normal foreskin ﬁbroblast cells. In
conclusion, Dioscorea nipponica potently inhibits melanoma
invasive and metastatic potential; therefore, they may consti-
tute a valuable tool in the combination therapy of metastatic
melanoma and in the prevention of melanoma metastases.
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